Zurich Cantonal Bank
MRVI icon

Zurich Cantonal Bank’s Maravai LifeSciences MRVI Stock Holding History

Zurich Cantonal Bank’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-47,031
Closed -$104K – 2609
2025
Q1 		$104K Buy
47,031
+16,914
+56% +$66.8K ﹤0.01% 2374
2024
Q4 		$164K Buy
30,117
+4,667
+18% +$30K ﹤0.01% 2239
2024
Q3 		$211K Hold
25,450
– – ﹤0.01% 2078
2024
Q2 		$182K Buy
25,450
+6,212
+32% +$53.6K ﹤0.01% 2086
2024
Q1 		$167K Hold
19,238
– – ﹤0.01% 2151
2023
Q4 		$126K Sell
19,238
-4,936
-20% -$31.9K ﹤0.01% 2337
2023
Q3 		$242K Buy
24,174
+7,264
+43% +$79.8K ﹤0.01% 1853
2023
Q2 		$210K Hold
16,910
– – ﹤0.01% 1895
2023
Q1 		$237K Sell
16,910
-684
-4% -$9.82K ﹤0.01% 1768
2022
Q4 		$252K Buy
17,594
+2,988
+20% +$47K ﹤0.01% 1690
2022
Q3 		$373K Hold
14,606
– – ﹤0.01% 1367
2022
Q2 		$415K Sell
14,606
-1,923
-12% -$60.9K ﹤0.01% 1342
2022
Q1 		$583K Buy
16,529
+2,177
+15% +$73K ﹤0.01% 1255
2021
Q4 		$601K Buy
14,352
+5,040
+54% +$204K ﹤0.01% 1309
2021
Q3 		$457K Hold
9,312
– – ﹤0.01% 1357
2021
Q2 		$389K Buy
+9,312
New +$361K ﹤0.01% 1376

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
PD
Point72 (DIFC) Dubai, United Arab Emirates $1.53B AUM 15.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Zurich Cantonal Bank's MRVI Position: Q2 2025 in Review

Zurich Cantonal Bank sold out of Maravai LifeSciences (MRVI) in Q2 2025, closing a stake of 47,031 shares — an estimated $104K sold.

Zurich Cantonal Bank first reported a position in MRVI in Q2 2021 and held it in 16 quarters. The position peaked at $601K in Q4 2021. 150 funds tracked by Wall St. Rank hold MRVI as of Q2 2025.

  • Zurich Cantonal Bank reported no remaining Maravai LifeSciences position as of Q2 2025 after selling out during the quarter.
  • Zurich Cantonal Bank sold 47,031 Maravai LifeSciences shares in Q2 2025, an estimated $104K.
  • Zurich Cantonal Bank first reported a position in Maravai LifeSciences in Q2 2021 and held it in 16 quarters.
  • Zurich Cantonal Bank's Maravai LifeSciences position peaked at $601K in Q4 2021.
  • 150 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2025.

Based on Zurich Cantonal Bank's 13F filing for Q2 2025, filed 7 Aug 2025.